Nina Lathia, BScPhm, RPh, MSc, PhD has spent more than 15 years helping health-care payers achieve value on their drug spend.

As the chief executive officer of Healthcare Decision Making, Nina works with public and private health-care payers, helping them to make evidence-based decisions about their pharmaceutical benefits that lead to improved health outcomes and long-term financial sustainability of their health plans. Her focus is on providing independent, actionable advice for health-care payers on reimbursement decisions related to expensive new specialty drugs.

Nina is a frequent public speaker and commentator on employer-sponsored pharmacy benefits design, value-based health-care decision-making and evidence-based medicine.

Nina honed her skills in value-based assessment of drug therapies when she was a senior technical advisor at the National Institute for Health and Care Excellence in the U.K. from 2014 to 2017. She has also worked as a clinical lecturer at the University of Toronto. Her work has been published in a number of high-impact peer review journals.

Nina holds a bachelor of science in pharmacy, as well as a master’s degree and doctorate in health economics from the University of Toronto.